GPHL on March 12th appointed Randy Schekman, the 2013 Nobel Laureate in Physiology or Medicine, as the chief scientist of both the group and its subsidiary Guangzhou General Pharmaceutical Research In
GPHL (Zhuhai Hengqin) Pharmaceutical Industrial Park Co., Ltd. has been established in the TCM Science and Technology Industrial Park of Co-operation between Guangdong and Macao in Zhuhai's Hengqin.
With the theme “Awesome Service, Amazing Guangdong”, the Guangdong Theme Day activity was held by the Guangdong province on September 3rd at the Fair.
Baiyunshan reports a 53% growth in net income attributable to shareholders net of non-recurring gain
On August 18th, GPHL’s listed arm Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (“Baiyunshan”, SH600332, HK0874) reported outstanding financial results for the first half of 2021.
GPHL ranked 468th on the Fortune Global 500 List, becoming the first company to enter this list with TCM as its major business.
On July 12th the National Conference on Symbiosis of Medical and Health Industries 2021 was held in Kunming, southwest China's Yunnan Province. The lists of 2020 China’s Top 100 Pharmaceutical Compani
On July 14th, in Guangzhou, GPHL entered into a strategic cooperation framework agreement with Guangzhou Branch of China CITIC Bank and CITIC Securities.
On March 2nd, 2021, GPHL, China's leading pharmaceutical and healthcare company, entered into a Memorandum of Understanding (MOU) to build strategic collaboration with Merck.
GPHL held the launching ceremony for a rural revitalization fund under the name of its beverage brand Ciningji and also realised a five-year action plan in Guangzhou.
GPHL has had a team of top talent including 3 Nobel laureates, 21 academicians and doctors as well as nearly 100 doctoral & post-doctoral researchers.
The press conference was hosted by Guangdong Laboratory for Lingnan Modern Agriculture (GLLMA) and organized by GPHL, with the guidance of the DARA.